Leadership Team

Leadership Team

Our multidisciplinary Team, led by professionals with a long track record in drug development and management, relies on highly skilled personnel with unique competence in developing integrated solutions.

  • Alex Zwyer, MBA

    Chief Executive Officer & Co-Founder

    Former Executive Vice President of Viforpharma (Specialty Pharma)
    Global responsibility for marketing / sales, regulatory and medical affairs
    Re-purposing expert
    Named ‘Healthcare CEO of the Year, Switzerland’ in 2018 by Business Worldwide
    Named one of ‘The 10 Best Performing Leaders to Watch, 2018’ by Insight Success

  • Robert Dickey IV, MBA

    Chief Financial Officer

    More than 25 years of experience as a CFO as well as in other C-level and Board positions in life sciences and medical device companies, both private and publicly-traded, across all stages of development
    Before that, Rob spent 18 years as an investment banker, mostly at Lehman Brothers, with a background split between M&A and capital markets transactions
    His expertise includes public and private financings, M&A, partnering/licensing, project management and managing company’s finance and accounting functions, as well as interactions with Boards, venture capitalists, shareholders and Wall Street
    Rob holds an AB from Princeton University and an MBA from The Wharton School, University of Pennsylvania

  • Hervé Girsault, MBA

    Chief Business Officer

    CBO of PIQUR Therapeutics AG (Basel)
    CEO, Synarc Inc. (San Francisco, CA)
    Head Novartis Pharma Out-Licensing & Partnering
    Global Head M&A/BD Novartis Consumer Health
    CEO Novartis Consumer Health, Benelux
    CEO Gerber Products Company (France)

  • Sandy Eisen, M.D.

    Chief Medical Officer

    Medical degree from Cambridge University U.K.
    Worked as U.K./EU regulator at MHRA and EMEA
    VP at Parexel advising over 50 companies on their development plans and providing regulatory advice
    CMO at TEVA Europe with overaching responsability for all medical affairs, clinical development and drug safety issues.